To Evaluate the Safety, Tolerability and Pharmacokinetic of SAL0133 Tablets in Chinese Adult Healthy Subjects
Clinical trial NCT07030504 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07030504
- Sponsor
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-10
- Primary completion
- 2025-06-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.